Wessely, S · Ciba Foundation symposium · 1993 · DOI
Quick Summary
This review examines how ME/CFS relates to psychiatric conditions and brain function. Rather than viewing ME/CFS as purely physical or purely psychological, the authors found evidence that brain system problems—particularly in the hypothalamus, a key control center—play an important role in the condition. The paper argues that understanding ME/CFS requires looking at both brain biology and mental health factors together.
Why It Matters
This work was influential in establishing that ME/CFS involves legitimate brain dysfunction rather than being a purely psychiatric or purely neurological condition. By calling for integration between psychiatric and neurological perspectives, it helped reduce stigma and redirect research toward understanding the biological mechanisms underlying the condition.
Observed Findings
Neuroendocrinological studies showed evidence of hypothalamic dysfunction in ME/CFS patients
Longitudinal studies demonstrated interactions between vulnerability to psychiatric disorder and development of CFS
Neuroimaging, neuropsychology, and neurophysiology studies provided evidence of disordered central nervous system function
Epidemiological evidence supported a central (brain-based) disorder component in CFS
Inferred Conclusions
Hypothalamic disorder may represent a final common pathway for ME/CFS pathogenesis
Psychiatric factors and neurobiological dysfunction both contribute to ME/CFS and should not be viewed as mutually exclusive explanations
An integrated approach bridging psychiatry and neurology is necessary for understanding ME/CFS
Remaining Questions
What specific hypothalamic dysfunctions occur in ME/CFS and what causes them?
How do psychiatric vulnerability factors interact with neurobiological changes to produce the full clinical picture?
Which symptoms are primary neurobiological features versus secondary to sustained illness?
What This Study Does Not Prove
This review does not establish specific causative mechanisms, only associations and evidence of CNS involvement. It cannot prove that hypothalamic dysfunction causes ME/CFS rather than resulting from it, nor does it identify which psychiatric symptoms are secondary to the illness versus contributory factors. The 1993 publication date means it does not incorporate later discoveries in neurobiology, immunology, and metabolic dysfunction.